Neurocrine Biosciences (NBIX) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $174.26 +3.87%
EPS Growth %: -4.2%
Financial Fact:
Research and development: 20.94M
Today's EPS Names:
PKE, LNN, More
EPS Growth %: -4.2%
Financial Fact:
Research and development: 20.94M
Today's EPS Names:
PKE, LNN, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q2 EPS of ($0.28), $0.01 better than the analyst estimate of ($0.29).
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- FactSet Research Systems (FDS) PT Raised to $253 at Jefferies
- Neurocrine Biosciences Initiates Phase 2 Study of Crinecerfont in Pediatric Patients Under 4 Years Old with Classic Congenital Adrenal Hyperplasia
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
